跳转至内容
Merck

LC/MS Analysis of 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 on Ascentis® Express F5

LC/MS Analysis of 25-Hydroxyvitamin D2 and 25-Hydroxyvitamin D3 on Ascentis® Express F5 application for HPLC

材料

分析柱

产品编号
说明
价格

Ascentis® Express F5, 2.7 μm HPLC 色谱柱

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

標準

产品编号
说明
价格

25-羟基维生素D3标准液 CRM 溶液

100 μg/mL in ethanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

column

Ascentis Express F5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53569-U)

mobile phase

5 mM ammonium formate in methanol:water (75:25)

flow rate

0.4 mL/min

column temp.

40 °C

detector

UV, 265 nm (MS, ESI(+), m/z 100-1000)

injection

1 μL

sample

20 μg/mL in methanol

说明

分析報告

The 25-OH forms of the secosteroids vitamin D2 and D3 are indicators of the vitamin D status of an individual. However, because they have different biological activity and clinical interest, they should be distinguishable. The Ascentis Express F5 phase was able to resolve the two compounds under highly LC-MS/MS compatible conditions. The highest grade LC-MS solvents were used to supply low background interference and low particulate contaminants for robust, trouble-free operation. Cerilliant CRMs provided reliable identification and quantification.

法律資訊

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany